This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Hemispherx Biopharma Inc (HEB)

AMEX: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 803.00K 2.21M 3.10M 2.92M
Receivables 0.00 0.00 0.00 0.00
Inventories 0.00 453.00K 897.00K 787.00K
Other Current Assets 358.00K 322.00K 0.00 0.00
Total Current Assets 18.55M 44.73M 31.79M 36.67M
Property, Plant & Equipment, Gross 16.43M 8.96M 9.78M 7.92M
Accumulated Depreciation & Depletion 4.33M 3.66M 3.02M 2.56M
Property, Plant & Equipment, Net 12.10M 5.29M 6.76M 5.36M
Intangibles 1.08M 1.03M 863.00K 794.00K
Other Non-Current Assets 136.00K 6.64M 4.10M 8.85M
Total Non-Current Assets 13.32M 12.97M 11.73M 15.01M
Liabilities & Shareholder Equity
Total Assets 31.87M 57.70M 43.51M 51.68M
Accounts Payable 1.27M 2.16M 1.68M 1.33M
Short Term Debt 33.00K 46.00K 1.74M 61.00K
Other Current Liabilities 0.00 7.05M 0.00 0.00
Total Current Liabilities 2.53M 12.65M 5.07M 2.83M
Long Term Debt 14.00K 0.00 380.00K 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 0.00 295.00K 0.00 2.80M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 37.00K 350.00K 479.00K 2.90M
Total Liabilities 2.57M 13.00M 5.55M 5.73M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 29.30M 44.70M 37.96M 45.95M
Common Par 168.00K 166.00K 136.00K 135.00K
Additional Paid In Capital 289.56M 288.67M 264.96M 264.51M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -260.32M -244.09M -226.74M -217.72M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -114.00K -43.00K -389.00K -974.00K
Total Capitalization 29.31M 44.70M 38.34M 45.95M
Total Equity 29.30M 44.70M 37.96M 45.95M
Total Liabilities & Stock Equity 31.87M 57.70M 43.51M 51.68M
Total Common Shares Outstanding 168.66M 166.49M 135.64M 132.79M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 167.33M 141.02M 135.43M 134.02M
Diluted Weighted Shares Outstanding 167.33M 141.02M 135.43M 134.02M
Number of Employees 39 34 47 29
Number of Part-Time Employees 0 3 12 27
HEB News

HEB Hemispherx Biopharma Inc

Analysts Ratings for HEB

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET HEB ANALYST REPORT

Brokerage Partners

HEB Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs